Back
Expedia Group Vs. ANI Pharmaceuticals Industry Stock Comparison
Buy
74
EXPE
Expedia Group
Last Price:
142.52
Seasonality Move:
4.68%
Buy
53
ANIP
ANI Pharmaceuticals
Last Price:
60.32
Seasonality Move:
0.29%
Buy
74
Expedia Group (EXPE)
is a Buy
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $139.70. The Score for EXPE is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- EXPE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.05. The Score for ANIP is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $139.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXPE is experiencing slight buying pressure.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.05
The current trend is relatively stagnant and ANIP is experiencing slight selling pressure.
EXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.64 | Buy |
| Relative Strength Index (14 RSI): | 60.84 | Buy |
| Chaikin Money Flow: | 475477 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (131.73 - 138.53) | Buy |
| Bollinger Bands (100): | (116.62 - 134.94) | Buy |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 52.65 | Buy |
| Chaikin Money Flow: | -163397 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.84 - 62.92) | Buy |
| Bollinger Bands (100): | (59.73 - 65.45) | Sell |
EXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 134.46 | Buy |
| 20-day SMA: | 135.84 | Buy |
| 50-day SMA: | 131.23 | Buy |
| 200-day SMA: | 133.47 | Buy |
| 8-day EMA: | 136.08 | Buy |
| 20-day EMA: | 134.59 | Buy |
| 50-day EMA: | 131.58 | Buy |
| 200-day EMA: | 127.71 | Buy |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.54 | Buy |
| 20-day SMA: | 60.34 | Buy |
| 50-day SMA: | 61.2 | Sell |
| 200-day SMA: | 61.23 | Sell |
| 8-day EMA: | 58.88 | Buy |
| 20-day EMA: | 59.62 | Buy |
| 50-day EMA: | 60.85 | Buy |
| 200-day EMA: | 60.54 | Buy |
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.13 per share, an increase next quarter of $1.06 per share, an increase this year of $2.07 per share, and an increase next year of $2.51 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.40 per share, an increase this year of $0.29 per share, and an increase next year of $0.99 per share.
Expedia Group Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||